Kabra Drugs bulk deals, insider trading and stake changes
BSE: 524322Pharmaceuticals & BiotechnologySmall Cap
Kabra Drugs Ltd · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1993
Last close ₹16.26up ₹0.40 (2.52%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹15.86.
28 Oct: open ₹16.80, high ₹16.80, low ₹15.30
52-week range of traded prices to 28 Oct 2026
₹15.30Low, 28 Oct 2026₹35.52High, 11 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹39 Cr3,225th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 5.08
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.30
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 28.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 21,705
Kabra Drugs' insiders have 8 trade disclosures on record, the latest on 24 Sep 2024. Its promoter group made no purchase or sale on the market in the 12 months to 28 Oct 2026.
Kabra Drugs insider trading
The company's own latest disclosure on record is from Sep 2024.Insider trading, all companies
Aug 2024
- Kuniamuthur Nanjappan Anand₹0.66 Cr6,58,500 sharesReceived · Director · 16 Aug 2024 · disclosed 20 Sep · Preferential Offer · held none before, holds 6,58,500 after
Dec 2019
- SHYAM KABRA₹0.48 Cr4,80,700 sharesSold · Promoter · 12 Dec 2019 · disclosed 13 Dec · held 4,80,700 before, holds none after
- KUSUM KABRA₹0.35 Cr3,45,500 sharesSold · Promoter · 9 Dec 2019 · disclosed 10 Dec · held 3,45,500 before, holds none after
- Kusum Kabra₹0.03 Cr34,45,500 sharesGave · Promoter · 9 Dec 2019 · disclosed 10 Dec · Market · held 3,45,500 before
- AYUSH KABRA₹0.22 Cr2,22,000 sharesSold · Promoter · 6 Dec 2019 · disclosed 7 Dec · held 2,22,000 before, holds none after
- Ayush Kabra₹0.02 Cr2,22,000 sharesGave · Promoter · 6 Dec 2019 · disclosed 7 Dec · Market · held 2,22,000 before
Aug 2016
- Ayush Kabra₹0.02 Cr2,22,000 sharesReceived · Immediate Relative · 3 Aug 2016 · disclosed 4 Aug · Off Market / Inter se transfer · holds 2,22,000 after, stake 5.06% after
- Khushbu Kabra₹0.22 Cr2,22,000 sharesGave · Promoter · 3 Aug 2016 · disclosed 4 Aug · Off Market / Inter se transfer · held 2,22,000 before
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Kabra Drugs stake sales and purchases
All 16 disclosures on record.
Aug 2024
- AcquiredKuniamuthur Nanjappan Anand6.53% of the company6,58,500 sharesholds 6.53% after16 Aug 2024 · filed under the 5% rule · Preferential allotment
Jul 2024
- AcquiredKuniamuthur Nanjappan Anand6.53% of the company6,58,500 sharesholds 6.53% after5 Jul 2024 · filed under the 5% rule · Preferential allotment
Dec 2019
- SoldShyam Kabra · promoter10.95% of the company4,80,700 shares12 Dec 2019 · filed under the 2% rule · Market
- SoldKusum Kabra · promoter7.87% of the company3,45,500 shares9 Dec 2019 · filed under the 2% rule · Market
- SoldAyush Kabra · promoter5.06% of the company2,22,000 shares6 Dec 2019 · filed under the 2% rule · Market
Aug 2016
- AcquiredAyush Kabra · promoter5.06% of the company2,22,000 sharesholds 5.06% after3 Aug 2016 · filed under the 2% rule · Inter-se Transfer
- SoldAyush Kabra · promoter5.06% of the company2,22,000 shares3 Aug 2016 · filed under the 2% rule · Inter-se Transfer
- AcquiredAyush Kabra5.06% of the company2,22,000 shares1 Aug 2016 · filed as exempt from an open offer
Oct 2014
- SoldShyam Kabra · promoter0.46% of the company20,000 sharesholds 10.94% after29 Oct 2014 · filed under the 2% rule · Market
- SoldShyam Kabra · promoter0.23% of the company10,000 sharesholds 11.39% after23 Oct 2014 · filed under the 2% rule · Market
- SoldShyam Kabra · promoter0.57% of the company25,000 sharesholds 11.22% after20 Oct 2014 · filed under the 2% rule · Market
- SoldShyam Kabra · promoter0.57% of the company25,000 sharesholds 11.79% after10 Oct 2014 · filed under the 2% rule · Market
- SoldShyam Kabra · promoter0.51% of the company20,000 sharesholds 12.36% after8 Oct 2014 · filed under the 2% rule · Market
Apr 2014
- SoldAyush Kabra · promoter0.38% of the company16,700 shares9 Apr 2014 · filed under the 2% rule · Off Market
Feb 2014
1 entry
- SoldShyam Kabra · promoter2.51% of the company1,10,000 sharesholds 12.81% after7 Feb 2014 · filed under the 2% rule · Off Market
Nov 2013
1 entry
- SoldAyush Kabra · promoter2.28% of the company1,00,000 sharesholds 0.38% after23 Nov 2013 · filed under the 2% rule · Off Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Kabra Drugs bulk deals
Last 12 months, since 28 Oct 2025: 7 bulk deals, ₹0.93 Cr bought and ₹1.99 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Friday 2 Jan 20261 firm · ₹0 bought · ₹0.42 Cr soldNet sold ₹0.42 Cr
- SoldKRUTI SEVANTI DOSHISold 1,30,810 at ₹31.820.55% of the company₹0.42 Cr
Thursday 1 Jan 20261 firm · ₹0 bought · ₹0.45 Cr soldNet sold ₹0.45 Cr
- SoldKRUTI SEVANTI DOSHISold 1,43,190 at ₹31.200.60% of the company₹0.45 Cr
Wednesday 24 Dec 20251 firm · ₹0 bought · ₹0.38 Cr soldNet sold ₹0.38 Cr
- SoldKRUTI SEVANTI DOSHISold 1,26,000 at ₹30.190.53% of the company₹0.38 Cr
Monday 22 Dec 20251 firm · ₹0 bought · ₹0.33 Cr soldNet sold ₹0.33 Cr
- SoldMIRAL HEMANTBHAI BHOOTSold 1,19,000 at ₹27.550.50% of the company₹0.33 Cr
Thursday 20 Nov 20253 firms · ₹0.93 Cr bought · ₹0.42 Cr soldNet bought ₹0.51 Cr
- BoughtSELVAMURTHY AKILANDESWARIBought 1,91,422 at ₹26.890.81% of the company₹0.51 Cr
- SoldVIJAY KUMAR REDDY VEERAMREDDYSold 1,50,519 at ₹27.630.63% of the company₹0.42 Cr
- BoughtSOUMYA MALANI .Bought 1,50,000 at ₹27.650.63% of the company₹0.41 Cr
Friday 18 Jul 20251 firm · ₹0.02 Cr bought · ₹0.30 Cr soldNet sold ₹0.29 Cr
- Both waysISHAAN TRADEFIN LLPBought 7,717 at ₹21.87Sold 1,36,442 at ₹22.260.58% of the companyNet −1,28,725 shares₹0.02 Cr bought
Wednesday 16 Jul 20251 firm · ₹0.28 Cr bought · ₹0 soldNet bought ₹0.28 Cr
- BoughtISHAAN TRADEFIN LLPBought 1,37,393 at ₹20.250.58% of the company₹0.28 Cr
Monday 14 Jul 20251 firm · ₹0.49 Cr bought · ₹0 soldNet bought ₹0.49 Cr
- BoughtISHAAN TRADEFIN LLPBought 2,60,000 at ₹18.841.10% of the company₹0.49 Cr
Monday 10 Jun 20242 firms · ₹0.04 Cr bought · ₹0.06 Cr soldNet sold ₹0.01 Cr
- SoldGOPALSINGH JAYSINGH SOLANKISold 73,407 at ₹7.911.67% of the company₹0.06 Cr
- BoughtVARSHA CHUGHBought 54,838 at ₹7.911.25% of the company₹0.04 Cr
Thursday 3 Sep 20201 firm · ₹81,900 bought · ₹0 soldNet bought ₹81,900
- BoughtKOTHARI VINOD FOJMALJIBought 30,000 at ₹2.730.68% of the company₹81,900
Monday 8 Jun 20202 firms · ₹0.02 Cr bought · ₹0.01 Cr soldNet bought ₹77,951
- BoughtP B PRADEEP .Bought 48,947 at ₹3.731.12% of the company₹0.02 Cr
- SoldLAVEKUSH GADIYASold 28,124 at ₹3.720.64% of the company₹0.01 Cr
Monday 1 Jun 20201 firm · ₹0.02 Cr bought · ₹0 soldNet bought ₹0.02 Cr
- BoughtP B PRADEEP .Bought 44,485 at ₹3.771.01% of the company₹0.02 Cr
Monday 23 Mar 20202 firms · ₹0.02 Cr bought · ₹0.02 Cr soldNet nil
- BoughtANUPRIYA SUREKHBought 88,368 at ₹2.822.01% of the company₹0.02 Cr
- SoldNANDKISHOR SIMAYASold 88,368 at ₹2.822.01% of the company₹0.02 Cr
Tuesday 11 Feb 20205 firms · ₹0.02 Cr bought · ₹0.02 Cr soldNet sold ₹61,761
- SoldAATUR BAKLIWALSold 62,374 at ₹1.841.42% of the company₹0.01 Cr
- BoughtSHILPA SATISHBought 50,000 at ₹1.841.14% of the company₹92,000
- BoughtM Y THULASI MANIBought 36,000 at ₹1.840.82% of the company₹66,240
- SoldROOPCHAND JAIN HUFSold 31,000 at ₹1.840.71% of the company₹57,040
- SoldLAVEKUSH GADIYASold 26,192 at ₹1.840.60% of the company₹48,193
Friday 31 Jan 20205 firms · ₹0.03 Cr bought · ₹0.03 Cr soldNet nil
- SoldAATUR BAKLIWALSold 2,30,000 at ₹1.405.24% of the company₹0.03 Cr
- BoughtK SATISHBought 70,750 at ₹1.411.61% of the company₹99,758
- BoughtVINAY KUMAR VBought 58,000 at ₹1.371.32% of the company₹79,460
- BoughtMANJUNATH B RBought 36,475 at ₹1.430.83% of the company₹52,159
- BoughtROOPCHAND JAIN HUFBought 31,000 at ₹1.430.71% of the company₹44,330
Friday 24 Jan 20202 firms · ₹80,109 bought · ₹78,718 soldNet nil
- BoughtRAHUL ANANTRAI MEHTABought 69,660 at ₹1.151.59% of the company₹80,109
- SoldSHILPA KUMARSold 68,450 at ₹1.151.56% of the company₹78,718
Tuesday 21 Jan 20202 firms · ₹45,083 bought · ₹45,083 soldNet nil
- BoughtARTHIBought 43,349 at ₹1.040.99% of the company₹45,083
- SoldRAMACHANDRAN MURALIDHARANSold 43,349 at ₹1.040.99% of the company₹45,083
Tuesday 14 Jan 20203 firms · ₹78,210 bought · ₹0.01 Cr soldNet nil
- SoldRAMACHANDRAN MURALIDHARANSold 79,800 at ₹0.991.82% of the company₹79,002
- BoughtB V CHANDAN YADAVBought 79,000 at ₹0.991.80% of the company₹78,210
- SoldDIVYAKANDASold 24,408 at ₹0.950.56% of the company₹23,188
Monday 13 Jan 20205 firms · ₹0.02 Cr bought · ₹0.02 Cr soldNet nil
- SoldAATUR BAKLIWALSold 1,20,000 at ₹0.992.73% of the company₹0.01 Cr
- BoughtDHEERAJ A KUMARBought 37,000 at ₹0.970.84% of the company₹35,890
- BoughtTEJA SHREE ABought 31,000 at ₹0.970.71% of the company₹30,070
- Both waysRAMACHANDRAN MURALIDHARANBought 1,20,000 at ₹0.99Sold 95,851 at ₹0.972.73% of the companyNet +24,149 shares₹0.01 Cr bought
- BoughtSHILPA KUMARBought 26,000 at ₹0.970.59% of the company₹25,220
Friday 10 Jan 20205 firms · ₹0.01 Cr bought · ₹0.01 Cr soldNet nil
- SoldLAVEKUSH GADIYASold 1,00,000 at ₹1.002.28% of the company₹0.01 Cr
- BoughtTEJA SHREE ABought 50,699 at ₹1.011.16% of the company₹51,206
- BoughtDHEERAJ A KUMARBought 48,000 at ₹1.011.09% of the company₹48,480
- BoughtSHILPA KUMARBought 42,050 at ₹1.010.96% of the company₹42,471
- SoldRAMACHANDRAN MURALIDHARANSold 30,000 at ₹1.030.68% of the company₹30,900
Thursday 9 Jan 20204 firms · ₹0.01 Cr bought · ₹0.01 Cr soldNet nil
- BoughtRAMACHANDRAN MURALIDHARANBought 1,12,000 at ₹0.982.55% of the company₹0.01 Cr
- Both waysLAVEKUSH GADIYABought 5,740 at ₹0.99Sold 99,096 at ₹0.982.26% of the companyNet −93,356 shares₹5,683 bought
- SoldSNEHA SANJEEV LUNKADSold 35,904 at ₹0.990.82% of the company₹35,545
- BoughtDIVYAKANDABought 24,408 at ₹0.990.56% of the company₹24,164
Wednesday 8 Jan 20202 firms · ₹32,501 bought · ₹28,603 soldNet nil
- BoughtDALCHAND .Bought 28,937 at ₹0.980.66% of the company₹28,358
- Both waysSNEHA SANJEEV LUNKADBought 4,227 at ₹0.98Sold 29,187 at ₹0.980.67% of the companyNet −24,960 shares₹4,142 bought
Thursday 19 Dec 20194 firms · ₹0.02 Cr bought · ₹0.02 Cr soldNet nil
- BoughtAATUR BAKLIWALBought 1,25,000 at ₹1.022.85% of the company₹0.01 Cr
- SoldROOPCHAND JAIN HUFSold 1,23,999 at ₹1.022.83% of the company₹0.01 Cr
- Both waysSANJEEV LUNKADBought 9,106 at ₹0.96Sold 78,000 at ₹1.021.78% of the companyNet −68,894 shares₹8,742 bought
- BoughtRAHUL ANANTRAI MEHTABought 45,556 at ₹1.021.04% of the company₹46,467
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. The latest 57 deals, on record from 4 Jan 2004.